Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 24, 2016
- Revision received April 1, 2016
- Accepted April 6, 2016
- Published online April 28, 2016.
Copyright & Usage
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- DANIEL SEIDL1,
- STEFAN JANSSEN1,2,
- PRIMOZ STROJAN3,
- SAMER G. HAKIM4,
- BARBARA WOLLENBERG5,
- STEVEN E. SCHILD6 and
- DIRK RADES1⇑
- 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
- 2Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
- 3Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
- 4Department of Oral and Maxillofacial Surgery and Oto-Rhino-Laryngology, University of Lübeck, Lübeck, Germany
- 5Department of Head and Neck Surgery, University of Lübeck, Lübeck, Germany
- 6Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
- Correspondence to: Professor Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. Tel: +49 4515006661, Fax: +49 4515003324, e-mail: rades.dirk{at}gmx.net
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer
- A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer
- Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with >=42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer